{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:59:51Z","timestamp":1790103591239,"version":"4.0.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Chronic obstructive pulmonary disease (COPD) is frequently complicated by cardiovascular disease (CVD), which significantly increases morbidity and mortality. The monocyte-to-high-density lipoprotein cholesterol ratio (MHR) has emerged as a novel inflammatory biomarker associated with various cardiovascular conditions. However, its relationship with CVD in COPD patients remains understudied. This study aimed to investigate the association between MHR and coexisting CVD in patients with COPD. This cross-sectional investigation analyzed the National Health and Nutrition Examination Survey data from 2007 to 2018, focusing on adults aged \u226540 years with physician-diagnosed COPD. The primary outcome encompassed cardiovascular conditions including congestive heart failure, coronary heart disease, angina pectoris, or myocardial infarction. MHR was analyzed both as a continuous variable and in quartiles. Four sequential logistic regression models were applied: Model 1 was unadjusted; Model 2 adjusted for sex, age, and race\/ethnicity; Model 3 further adjusted for education, marital status, smoking, and poverty-income ratio; Model 4 additionally adjusted for hypertension, diabetes, and body mass index. Dose\u2013response relationships were assessed using restricted cubic splines. A total of 1064 COPD patients were included (mean age, 62.8\u2005\u00b1\u200510.5 years; 56.6% female), of whom 206 (19.4%) had coexisting CVD. Compared with patients without CVD, those with CVD were older (median, 68 vs 61 years;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), more often male (62.1% vs 38.9%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), and had a higher prevalence of diabetes (43.2% vs 24.4%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001) and hypertension (82.5% vs 54.6%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). MHR levels were higher in the CVD group than in the non-CVD group (0.542 vs 0.423;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). In the fully adjusted model, each 1-unit increase in MHR was associated with higher odds of CVD (odds ratio, 3.27; 95% confidence interval, 1.59\u20136.74;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). A graded association was observed across MHR quartiles (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend\u2005&lt;\u2005.001), with the highest quartile showing greater odds of CVD than the lowest (odds ratio, 2.70; 95% confidence interval, 1.57\u20134.73;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Restricted cubic spline analysis indicated a nonlinear positive association between MHR and CVD. In COPD patients, higher MHR was independently associated with a greater prevalence of coexisting CVD, with a graded and nonlinear pattern. Given the cross-sectional design, causal inference is not warranted, and prospective studies are needed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050756","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:01:58Z","timestamp":1789750918000},"page":"e50756","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Monocyte-to-HDL cholesterol ratio and cardiovascular comorbidity in COPD"],"prefix":"10.1097","volume":"105","author":[{"given":"Chengying","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Nanjing Lishui People\u2019s Hospital (Zhongda Hospital Lishui Branch, Southeast University), Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiao","family":"Luan","sequence":"additional","affiliation":[{"name":"Department of Lung, The Third People\u2019s Hospital of Yangzhou, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3562-4272","authenticated-orcid":false,"given":"Yuhui","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Nanjing Lishui People\u2019s Hospital (Zhongda Hospital Lishui Branch, Southeast University), Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0140-6736(22)00470-6","article-title":"Chronic obstructive pulmonary disease.","volume":"399","author":"Christenson","year":"2022","journal-title":"Lancet"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-2600(23)00461-7","article-title":"GOLD COPD report: 2024 update.","volume":"12","author":"Venkatesan","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R3-20260922","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/14779072.2024.2333786","article-title":"Cardiovascular disease and risk in COPD: a state of the art review.","volume":"22","author":"Polman","year":"2024","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fimmu.2014.00435","article-title":"Role of alveolar macrophages in chronic obstructive pulmonary disease.","volume":"5","author":"Vlahos","year":"2014","journal-title":"Front Immunol"},{"key":"R5-20260922","first-page":"1299","article-title":"Cardiovascular diseases in COPD: from diagnosis and prevalence to therapy.","volume":"13","author":"Trigonis","year":"2023","journal-title":"Life (Basel)"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"944991","DOI":"10.3389\/fendo.2022.944991","article-title":"Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R7-20260922","doi-asserted-by":"crossref","first-page":"e30109","DOI":"10.1097\/MD.0000000000030109","article-title":"Monocyte to high-density lipoprotein ratio predict long-term clinical outcomes in patients with coronary heart disease: a meta-analysis of 9 studies.","volume":"101","author":"Liu","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"R8-20260922","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12944-022-01638-6","article-title":"Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States.","volume":"21","author":"Jiang","year":"2022","journal-title":"Lipids Health Dis"},{"key":"R9-20260922","first-page":"1","article-title":"National Health and Nutrition Examination Survey, 2015\u20132018: sample design and estimation procedures.","volume":"184","author":"Chen","year":"2020","journal-title":"Vital Health Stat 2"},{"key":"R10-20260922","first-page":"65","article-title":"Relationship between the monocyte-to-HDL-C ratio (MHR) and COPD: a cross-sectional study based on NHANES 2009\u20132018.","volume":"19","author":"Wang","year":"2025","journal-title":"Egypt J Bronchol"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41409-019-0679-x","article-title":"Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians.","volume":"55","author":"Gauthier","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"755806","DOI":"10.3389\/fcvm.2021.755806","article-title":"Adjustment of the GRACE risk score by monocyte to high-density lipoprotein ratio improves prediction of adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.","volume":"8","author":"Ma","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R13-20260922","doi-asserted-by":"crossref","first-page":"1609798","DOI":"10.3389\/fcvm.2025.1609798","article-title":"Evaluation of the prognosis of elderly patients with heart failure by monocyte-to-high-density lipoprotein ratio, neutrophil gelatinase-associated lipocalin, and angiotensin II.","volume":"12","author":"Liu","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/cns.14152","article-title":"Monocyte to high-density lipoprotein ratio predicts clinical outcomes after acute ischemic stroke or transient ischemic attack.","volume":"29","author":"Xu","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s12872-023-03461-y","article-title":"Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases.","volume":"23","author":"Pei","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/njcp.njcp_54_19","article-title":"Could monocyte level\/HDL cholesterol ratio predict cardiovascular diseases in patients with COPD?","volume":"23","author":"Yakar","year":"2020","journal-title":"Niger J Clin Pract"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/jcm13030743","article-title":"Comorbidities in COPD: current and future treatment challenges.","volume":"13","author":"Maccioni","year":"2024","journal-title":"J Clin Med"},{"key":"R18-20260922","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/jpm14090996","article-title":"Dysfunctional high-density lipoprotein cholesterol and coronary artery disease: a narrative review.","volume":"14","author":"Madaudo","year":"2024","journal-title":"J Pers Med"},{"key":"R19-20260922","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.3390\/ijms23158128","article-title":"High-density lipoproteins: a role in inflammation in COPD.","volume":"23","author":"Kotlyarov","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12944-017-0594-3","article-title":"The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.","volume":"16","author":"Femlak","year":"2017","journal-title":"Lipids Health Dis"},{"key":"R21-20260922","first-page":"e18273","article-title":"The effect of statin therapy on inflammatory biomarkers: a systematic review.","volume":"13","author":"Proute","year":"2021","journal-title":"Cureus"},{"key":"R22-20260922","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3233\/JAD-230374","article-title":"Reliability and validity of self-reported vascular risk factors: hypertension, diabetes, and heart disease, in a multi-ethnic community based study of aging and dementia.","volume":"95","author":"Lee","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"R23-20260922","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/diagnostics11040618","article-title":"The importance of appropriate diagnosis in the practical management of chronic obstructive pulmonary disease.","volume":"11","author":"Hashimoto","year":"2021","journal-title":"Diagnostics (Basel)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:03:42Z","timestamp":1790100222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050756"}},"subtitle":["Evidence from NHANES 2007 to 2018"],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":23,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050756","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2026-03-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}